Top Markets
Coin of the day
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Classement en actions #12604
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Prix de l'action
$9.09
Dernière synchronisation: 2023-06-23
Capitalisation boursière
$567.77M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange CTI BioPharma Corp. (CTIC)

Catégorie

Historique des divisions d’actions pour CTI BioPharma Corp. (CTIC)
L’action CTI BioPharma Corp. (symbole : CTIC) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 31, 2026.
Une action CTIC achetée avant le Aug 31, 2026 équivaudrait aujourd’hui à 0 actions CTIC.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH